Enzo Biochem Balance Sheet Health
Financial Health criteria checks 6/6
Enzo Biochem has a total shareholder equity of $47.7M and total debt of $231.0K, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are $75.3M and $27.6M respectively.
Key information
0.5%
Debt to equity ratio
US$231.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$47.74m |
| Equity | US$47.66m |
| Total liabilities | US$27.63m |
| Total assets | US$75.29m |
Recent financial health updates
Will Enzo Biochem (NYSE:ENZ) Spend Its Cash Wisely?
Nov 19
Is Enzo Biochem (NYSE:ENZ) Using Debt Sensibly?
May 18Is Enzo Biochem (NYSE:ENZ) A Risky Investment?
Jan 03Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?
Oct 04Recent updates
Enzo Biochem, Inc.'s (NYSE:ENZ) 33% Share Price Plunge Could Signal Some Risk
Dec 18Will Enzo Biochem (NYSE:ENZ) Spend Its Cash Wisely?
Nov 19Enzo Biochem: Is This Time Finally Different?
Jul 17Enzo Biochem: Cleaned Up And Cash-Rich But Unloved
Oct 26Is Enzo Biochem (NYSE:ENZ) Using Debt Sensibly?
May 18Is Enzo Biochem (NYSE:ENZ) A Risky Investment?
Jan 03Enzo Biochem Non-GAAP EPS of -$0.18, revenue of $18.28M
Dec 12Enzo Biochem appoints Patricia Eckert as interim CFO
Oct 20Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M
Oct 14Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?
Oct 04Enzo Biochem: Activist Pressure Could Finally Lead To A Company Sale
Jun 27Is Enzo Biochem (NYSE:ENZ) Using Debt In A Risky Way?
May 03Is Enzo Biochem (NYSE:ENZ) A Risky Investment?
Dec 17Health Check: How Prudently Does Enzo Biochem (NYSE:ENZ) Use Debt?
Aug 24Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?
Mar 01Is Enzo Biochem, Inc. (NYSE:ENZ) Popular Amongst Insiders?
Feb 03If You Had Bought Enzo Biochem's (NYSE:ENZ) Shares Three Years Ago You Would Be Down 66%
Jan 08
Enzo Biochem nabs expanded EUA nod for testing of COVID samples
Jan 04Enzo Biochem: Betting On The Activists Now
Dec 16Here's What We Think About Enzo Biochem's (NYSE:ENZ) CEO Pay
Dec 13Financial Position Analysis
Short Term Liabilities: ENZ's short term assets ($59.7M) exceed its short term liabilities ($23.4M).
Long Term Liabilities: ENZ's short term assets ($59.7M) exceed its long term liabilities ($4.2M).
Debt to Equity History and Analysis
Debt Level: ENZ has more cash than its total debt.
Reducing Debt: ENZ's debt to equity ratio has reduced from 5.5% to 0.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ENZ has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ENZ has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 28% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 13:08 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Enzo Biochem, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bradley Berning | Craig-Hallum Capital Group LLC |
| Reni Benjamin | Rodman & Renshaw, LLC |
| Jack Wallace | Sidoti & Company, LLC |